$49.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
SLU-PP-332 5mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
SLU-PP-332 5mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | [To be confirmed] |
|---|---|
| Molecular Formula | [To be confirmed] |
| Molecular Weight | [To be confirmed] |
| Purity | ≥99% |
| Sequence | [Pending disclosure or proprietary] |
| Applications | Appetite suppression, energy regulation, metabolic research, insulin pathway studies |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water/Sterile Diluent |
| Stability & Storage | Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Appearance | White to off-white powder |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | MSDS available upon request |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy SLU-PP-332 online should evaluate SLU-PP-332 as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, SLU-PP-332 COA review, purity documentation, lot traceability, product labeling, and storage information. This guide explains how to evaluate SLU-PP-332 for controlled research procurement through Pure Lab Peptides, with attention to RUO supplier documentation and identity testing.
Researchers can buy SLU-PP-332 online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase buy SLU-PP-332 online is addressed here as laboratory research procurement intent, not personal-use intent. In a compliant RUO context, the search intent belongs to qualified researchers, laboratory buyers, research institutions, and technical procurement teams comparing supplier documentation before adding a research material to a controlled inventory.
That procurement review is documentation-first. Buyers should confirm that the product is labeled for research use only, that the batch-specific COA is available, that the lot number on the label can be matched to documentation, and that the supplier language avoids claims about human outcomes, animal outcomes, dosing, administration, or therapeutic positioning.
FDA RUO/IUO guidance is specific to in vitro diagnostic products, but it provides a useful compliance principle: labeling should be consistent with intended use. This article applies that principle only as a general documentation boundary for research procurement, not as a classification of SLU-PP-332 as an IVD product [1].
SLU-PP-332 is identified in chemical databases as a small-molecule research compound with the formula C18H14N2O2 and CAS number 303760-60-3; PubChem also lists chemical names and structural identifiers that can support identity review in laboratory records [2]. Because it is a non-peptide small molecule, researchers should avoid assuming that peptide-category handling language automatically describes its chemistry. The practical procurement question is whether the supplied material, labeling, and COA align with the stated SLU-PP-332 identity.
Published literature has characterized SLU-PP-332 as a synthetic agonist of estrogen-related receptors, including ERRalpha, ERRbeta, and ERRgamma, with emphasis on ERRalpha-dependent pathway models [3]. Estrogen-related receptors were originally identified as a class of nuclear receptor homologs and are commonly discussed as orphan nuclear receptors in the scientific literature [4]. In research writing, this context should remain neutral: it describes receptor and transcriptional-model literature, not product-use claims.
Review literature describes ERRs as transcriptional regulators that appear in research related to cellular energy homeostasis, mitochondrial gene networks, and coactivator-mediated signaling [5]. Other reviews discuss constitutive ERR activity, ERRalpha and ERRgamma biology, and relationships among nuclear receptor pathways in metabolic research models [6] [7] [8]. Foundational work on ERRalpha and PGC-1alpha-dependent transcriptional programs is also part of the broader research background [9].
For procurement purposes, this means SLU-PP-332 should be handled as an SLU-PP-332 research material whose identity is documented through chemical naming, molecular data, analytical testing, and lot-specific records. Pathway relevance in published research does not create a claim about a supplied RUO material. Review literature on ERRalpha reinforces that the receptor is an important research topic, but it does not replace supplier documentation, COA review, or controlled laboratory recordkeeping [10].
Researchers search “buy SLU-PP-332 online” to evaluate whether a research supplier provides transparent SLU-PP-332 supplier documentation rather than unsupported claims. That evaluation includes RUO product availability, product form, analytical method references, purity data, identity confirmation, lot traceability, and storage documentation. The buying question is therefore not “what can the material do?” but “how well is this research-use-only material documented?”
A technical procurement team may also search buy SLU-PP-332 when comparing catalog pages, COA access, lot-number matching, shipping practices, and supplier language. A strong research procurement page should make it easy to verify the product name, the fill size, the labeled intended use, and the availability of batch-specific documentation. A weak page relies on consumer-style claims or outcome language rather than analytical records.
For SLU-PP-332 research-use-only procurement, the safest search-intent response is to keep the purchasing framework narrow: RUO labeling, COA access, purity documentation, identity testing, product form, storage information, and supplier transparency.
Researchers evaluating buy SLU-PP-332 online for laboratory research should prioritize evidence of identity, purity, batch traceability, and RUO language. The following quality signals help procurement teams separate documentation-focused suppliers from pages that depend on promotional claims.
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data where available | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
A strong SLU-PP-332 COA should help researchers connect the material in hand to the product record and the supplier’s quality file. Procurement teams should review the compound name, lot number, test date, stated purity percentage, analytical method, identity confirmation, product form, and storage documentation. For SLU-PP-332 identity testing, method details matter because a purity number without identity support is incomplete.
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. ICH Q2(R2) describes validation considerations for analytical procedures, while ICH Q14 describes science- and risk-based analytical procedure development [11] [12]. These references are not product claims; they provide neutral analytical context for evaluating documentation quality.
Chromatographic review is also important. USP General Chapter <621> describes chromatography terms, calculations, and system-suitability concepts, which helps explain why HPLC and related chromatographic records can support purity evaluation [13]. LC-MS combines chromatographic separation with mass-based detection, making it useful in many laboratory settings for compound characterization and identity confirmation [14]. Mass spectrometry literature also emphasizes that identification depends on method, evidence, and interpretive criteria, not a single number alone [15].
Laboratory procurement teams should keep the review workflow simple and auditable. First, confirm RUO labeling. Second, match the lot number. Third, review identity and purity evidence. Fourth, record storage and handling requirements. ISO/IEC 17025 describes competence and valid-result expectations for testing and calibration laboratories, while NIST describes reference-material certificates as documentation that can report intended use, certified values, and characterization data [16] [17]. Storage review is also a standard quality concern; ICH Q1A(R2) provides a regulatory example of stability documentation principles for drug substances and products, which can inform general laboratory thinking about storage records without converting SLU-PP-332 into a drug product [18].
Published literature has examined SLU-PP-332 primarily as a chemical probe for ERR pathway research. The 2023 ACS Chemical Biology article reported the identification of SLU-PP-332 as a synthetic ERRalpha/beta/gamma agonist and evaluated receptor and model-system questions [3]. That literature belongs in scientific context, not product-use guidance.
Additional preclinical literature has examined SLU-PP-332 in disease-model and pathway-model settings. A 2024 Journal of Pharmacology and Experimental Therapeutics paper evaluated the compound in metabolic-disease models [19]. A 2023 American Journal of Pathology paper examined ERR agonism in aging-kidney models [20]. A 2024 Circulation paper investigated pan-ERR agonists, including SLU-PP-332 and SLU-PP-915, in cardiac disease models [21]. These studies should be described as preclinical research context, not as claims for an RUO material.
Related medicinal-chemistry literature has also examined SLU-PP-915 and the broader pan-ERR agonist series. Hampton and coauthors reported development and pharmacological evaluation of a chemical series that identified SLU-PP-915 [22]. A later JPET paper characterized SLU-PP-915 in relation to ERR research and compared it with prior SLU-PP-332 work [23]. Structure-activity work on the SLU-PP-332 scaffold has continued, with a 2026 article discussing SAR and ERR signaling insights [24]. Recent analytical literature has used LC-HRMS/MS to characterize SLU-PP-332 and related pan-ERR agonists in vitro [25].
Metabolic pathway literature should not be translated into weight-loss, performance, or wellness claims for RUO materials. I did not identify human clinical literature for SLU-PP-332 in the cited sources. Even if future published clinical literature appears, it should not be interpreted as use guidance for research-use-only materials.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, chemical names, formula, and registry identifiers | Database / analytical | Supports identification, not product-use claims [2] |
| Pathway or category context | ERR receptor signaling, transcriptional regulation, and metabolic-pathway models | Review / in vitro / preclinical | Useful for research context, not therapeutic claims [5] [3] |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review [11] [14] |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning [18] |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “SLU-PP-332 is discussed in published research related to ERR signaling and metabolic pathway models.” | Describes literature context without making a product claim | “SLU-PP-332 helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy SLU-PP-332 for results.” |
| “Pure Lab Peptides supplies SLU-PP-332 as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies SLU-PP-332 for therapy.” |
| “The phrase buy SLU-PP-332 online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy SLU-PP-332 online for personal use.” |
| “SLU-PP-332 purity documentation should be reviewed with identity testing and lot records.” | Connects analytical quality review to procurement | “A purity percentage proves everything about the material.” |
Pure Lab Peptides presents SLU-PP-332 as a research-use-only material for laboratory procurement. The product is supplied as SLU-PP-332 5mg in lyophilized powder form, with a stated >=99% purity claim and batch-specific COA documentation available for review. Researchers should review the product page and batch-specific documentation rather than relying on generalized compound descriptions.
Review the Pure Lab Peptides SLU-PP-332 research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation. For broader catalog comparison, researchers can also review the research peptide collection, the Pure Lab Peptides blogs, and the shipping and returns information. The procurement review should focus on labeling, product-page documentation, storage and handling documentation, lot-level traceability, and supplier transparency.
Buy SLU-PP-332 online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published literature can help researchers understand why SLU-PP-332 appears in ERR pathway research, but it does not establish use instructions for an RUO material. Journal articles, database records, and analytical papers should be used as scientific context and documentation support, not as directions for human, animal, therapeutic, diagnostic, or consumer use.
Purity is only one part of SLU-PP-332 quality review. Researchers should evaluate the stated purity with identity testing, method information, lot number, product name, and COA consistency. A high purity claim without identity support is not a complete procurement record.
For research procurement, batch-specific COA review is a central quality signal. A generic example COA may explain a supplier’s format, but the working laboratory record should match the lot received. Lot-level traceability helps connect the product label, COA, storage record, and purchasing file.
SLU-PP-332 pathway literature should remain separated from marketing claims. A compound may be studied in ERR or metabolic-pathway models without supporting claims about a supplied RUO material. Procurement teams should prioritize documentation and avoid pages that convert pathway relevance into expected outcomes.
Researchers can buy SLU-PP-332 online for laboratory research by reviewing RUO suppliers that provide clear labeling, batch-specific COA access, purity information, identity documentation, and storage guidance. Pure Lab Peptides provides an SLU-PP-332 5mg product page for research procurement review, including RUO-focused product details and batch-specific documentation.
Before buying SLU-PP-332 online, researchers should check RUO labeling, product name consistency, batch-specific COA availability, lot number matching, purity documentation, identity testing, product form, and storage information. Supplier language should also remain research-focused and avoid dosing, therapeutic, diagnostic, personal-use, or consumer-outcome claims.
A COA matters when buying SLU-PP-332 because it helps connect the supplied material to batch-level documentation. Researchers should review the SLU-PP-332 COA for product name, lot number, test date, purity data, analytical method, and identity information. The COA supports procurement review; it does not create product-use guidance.
SLU-PP-332 discussed here is not intended for human or animal consumption. It is addressed only as a research-use-only laboratory material for qualified researchers and technical procurement teams. This article does not provide dosing, preparation, administration, therapeutic, diagnostic, veterinary, or consumer-use information.
Research use only means SLU-PP-332 is positioned as a laboratory research material, not as a consumer product, medicine, supplement, diagnostic tool, or veterinary material. RUO procurement review should focus on labeling, COA access, purity documentation, identity testing, lot traceability, storage information, and supplier transparency.
Published literature about SLU-PP-332 should be interpreted as scientific context for controlled research questions. Researchers may use literature to understand compound identity, ERR pathway background, and analytical characterization, but published findings should not be converted into product-use guidance or claims for an RUO material.
Qualified researchers evaluating SLU-PP-332 should review product labeling, COA status, identity documentation, storage information, and supplier transparency. Review the SLU-PP-332 product page for RUO labeling, purity information, and available batch-specific documentation before selecting any research-use-only material.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.